Astra Zeneca investerar miljarder i ny anläggning i USA

Svensk-brittiska Astra Zeneca satsar på cellterapier. Nu investerar läkemedelsbolaget 300 miljoner dollar, motsvarande cirka 3,1 miljarder svenska kronor, i en ...

Roche’s Genentech terminates licencing deal with Norwegian biotech

Genentech is ending a license collaboration with Norwegian biotech Nykode Therapeutics regarding a clinical stage cancer vaccine program.

Elicera develops CAR-T against solid tumours – may become the first in the world

Today, there are five EU-approved CAR-T therapies, all focused on different types of blood cancer, but no one has yet succeeded in making the method work agains...

Marie Gårdmark: Potential step change – EU regulators get to play with data

A new pilot from EMA is starting in September to assess wether the analysis of 'raw data' by regulatory authorities improves the evaluation of marketing approva...

Extremely high sample throughput rates

Precision and reliability in automated liquid handling

Pfizer’s Paxlovid is being tested against post-COVID in a major Swedish study

In a new study conducted at the Karolinska University Hospital, Pfizer’s COVID drug, Paxlovid, is now being tested in patients with post-COVID. The study is one...

Uppsalabolag prisas för utveckling av snabbtest för antibiotikaresistens

Uppsalabolaget Sysmex Astrego prisas för sitt antibiotikakänslighetstest. Företaget tilldelades under onsdagen the Longitude Prize och får ta emot 8 miljoner pund.

“I am driven by the desire to develop a product that can be sold worldwide”

Ranked number one in the world by the WHO in diarrhoea research and soon in phase III studies for its vaccine candidate – Scandinavian Biopharma is rushing forw...

Elypta awarded one million USD from the Star Trek creator’s foundation

Swedish company Elypta, which develops methods for early cancer detection, has been awarded one million USD from an unexpected source: a foundation set up in me...

Kriget i Ukraina ger bränsle åt totalt resistenta bakterier

Krigshärjade Ukraina lider inte bara av fientliga attacker från en utländsk angripare, utan också från hotet från en totalt resistent och smittsam bakterie.

Double up for Korbinian Löbmann

This year, Korbinian Löbmann will moderate the New Updates in Drug Formulation & Bioavailability meeting in Copenhagen for the fifth time. Furthermore, he will ...

Founder of Bioarctic, Lars Lannfelt, is honoured: “I want to create something for the future”

It´s like a scientist’s dream: to be the world’s first with a drug that genuinely affects one of our major diseases. Lars Lannfelt and his company Bioarctic hav...

Bättre kontroll på ventilerna och ökad produktivitet

Vi introducerar SORIO - Den nya generationens kontrolltopp för optimal ventilhantering.

Study: Vaccination linked to lower risk of post-COVID

The risk of developing post-COVID after a COVID infection was reduced in vaccinated people, according to a new study from the University of Gothenburg.

Hansa tar in 372 miljoner inför USA-lansering: "Starkt intresse"

Lundbaserade Hansa Biopharma har tagit in 372,2 miljoner kronor i en riktad nyemission där flera amerikanska specialistinvesterare deltar.

Life Science Sweden´s international issue is on its way

A new issue of Life Science Sweden is on its way to print, packed with news, interviews and reports.

Karolinska nionde bästa sjukhuset i världen i ny rankning

Återigen rankar Newsweek de bästa sjukhusen i världen. I år har de listat de sjukhus som är bäst på att använda ny teknik. Karolinska universitetssjukhuset utmä...

Nytt program ska hjälpa akademisk forskning till marknaden

Steget från akademisk forskning till kommersialisering inom life science är ofta tufft. Nu lanseras ett nytt finanseringsprogram för att överbrygga gapet.

Samuel Lagercrantz: The government’s performance in healthcare and life sciences so far

Since the change of government in Sweden, developments in the healthcare sector have shown promising signs, but the outlook in life sciences is less promising, ...

Cobra tillverkar andra generationens coronavaccin

I Matfors utanför Sundsvall tillverkar Cobra Biologics ett covid-19-vaccin som kan komma till användning även mot muterade former av sars-cov-2 eller mot helt n...

Galenica AB

Webinar: Automate your processes

Free ZEISS webinar on January 30th, 2025.

Before you choose a CRO

– We are a small company and it is very important for us to maintain our core competence within development of novel nanomaterials, Tove Sivik Sonne, Head of De...

Stark comeback för Affibody-kandidat efter misslyckande i fjol

Positiva data rapporteras för Affibodys läkemedelskandidat Izokibep vid behandling av psoriasisartrit (PsA) i en fas IIb/III-studie.